Nantahala Capital Management LLC 13D and 13G filings for Eagle Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-02-19 4:32 pm Purchase |
2025-02-16 | 13G | Eagle Pharmaceuticals, Inc. EGRX |
Nantahala Capital Management LLC | 4,945,209 38.078% |
1,000,000 (+25.35%) |
Filing |
| 2024-11-05 4:32 pm Purchase |
2024-10-31 | 13G | Eagle Pharmaceuticals, Inc. EGRX |
Nantahala Capital Management LLC | 3,945,209 30.400% |
1,983,139 (+101.07%) |
Filing |
| 2024-07-03 2:02 pm Purchase |
2024-06-30 | 13G | Eagle Pharmaceuticals, Inc. EGRX |
Nantahala Capital Management LLC | 1,962,070 15.100% |
1,962,070 (New Position) |
Filing |